Of note, PGE2, which is the most abundant prostanoid in colorectal cancer, promotes anti-tumor immune responses by inducing Treg and MDSCs [30] and promotes tumor initiation and growth by upregulating the expression of DNMT1 and DNMT3B [58]. The gene discussed is DNMT3B; the disease is neoplasm.